Mitochondrial Rac1 GTPase Import and Electron Transfer from Cytochrome c Are Required for Pulmonary Fibrosis*
- Heather L. Osborn-Heaford‡,1,
- Alan J. Ryan‡,1,
- Shubha Murthy‡,1,
- Ana-Monica Racila‡,
- Chao He§,
- Jessica C. Sieren¶,
- Douglas R. Spitz§ and
- A. Brent Carter‡§‖,2
- From the Departments of ‡Internal Medicine and
- §Radiation Oncology, Free Radical and Radiation Biology Program, and
- ¶Department of Radiology, University of Iowa Carver College of Medicine, and
- ‖Human Toxicology Program, University of Iowa College of Public Health, Iowa City, Iowa 52242
- ↵2 To whom correspondence should be addressed: University of Iowa Carver College of Medicine, C33 GH, 200 Hawkins Dr., Iowa City, IA 52242. E-mail: brent-carter{at}uiowa.edu.
-
↵1 These authors contributed equally to this work.
Abstract
The generation of reactive oxygen species, particularly H2O2, from alveolar macrophages is causally related to the development of pulmonary fibrosis. Rac1, a small GTPase, is known to increase mitochondrial H2O2 generation in macrophages; however, the mechanism by which this occurs is not known. This study shows that Rac1 is localized in the mitochondria of alveolar macrophages from asbestosis patients, and mitochondrial import requires the C-terminal cysteine of Rac1 (Cys-189), which is post-translationally modified by geranylgeranylation. Furthermore, H2O2 generation mediated by mitochondrial Rac1 requires electron transfer from cytochrome c to a cysteine residue on Rac1 (Cys-178). Asbestos-exposed mice harboring a conditional deletion of Rac1 in macrophages demonstrated decreased oxidative stress and were significantly protected from developing pulmonary fibrosis. These observations demonstrate that mitochondrial import and direct electron transfer from cytochrome c to Rac1 modulates mitochondrial H2O2 production in alveolar macrophages pulmonary fibrosis.
Footnotes
-
↵* This work was supported, in whole or in part, by National Institutes of Health Grants ES015981 and ES014871(to A. B. C.), CA133114 (to D. R. S.), P30 CA086862 (to University of Iowa Cancer Center), and UL1RR024979 (to University of Iowa Institute of Clinical and Translational Science). This work was also supported by a Merit Review from the Department of Veterans Affairs (to A. B. C.).
- Received September 27, 2011.
- Revision received November 21, 2011.
- © 2012 by The American Society for Biochemistry and Molecular Biology, Inc.











